Development of the technology and resulting products has been funded in the past by several Dutch and European grants and awards, including Dutch (STW Valorisation and Pre Seed) and European (Meditrans) grants. These enabled the preclinical as well as the commercial development of the nanoparticulate product portfolio. Furthermore, the work has been awarded by the Thesis Award 2008 of the Dutch Association for Pharmaceutical Sciences, the Simon Stevin Gezel Award 2008 and the Niaba BioBusiness Award 2010.